reiman leading trial roche antibody drug crenezumab failed large trials drugs falter larger trials setback alzheimer research general says gandy main concern pipeline amyloid reducing agents pretty spare says companies developing alternate therapies including antibodies target different protein tau destroys neurons advanced alzheimer disease sara reardon freelance journalist based bozeman mont. staff reporter master degree molecular biology 4 hours ago robin lloyd | 7 hours ago tanya lewis josh fischman jeffery delviscio sunya bhutta 8 hours ago eli m. cahan | 11 hours ago matthew hutson 12 hours ago sarah katz february 25 2021 naomi oreskes discover world changing science